Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
5aFFZN6WnzRvVww3
Listen
